European Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading

European equities traded in the US as American depositary receipts were nudging marginally lower late Wednesday morning with the S&P Europe Select ADR Index declining 0.09% to 1,399.82.

From continental Europe, the gainers were led by biopharmaceutical company Genfit (GNFT) and biotech firm Evaxion Biotech (EVAX), which rose 3.7% each. They were followed by semiconductor company Sequans Communications (SQNS) and telecommunications operator Telefonica (TEF), which increased 3.3% and 2.9% respectively.

The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and medical device maker EDAP TMS (EDAP), which dropped 6.2% and 1.5% respectively. They were followed by Ericsson (ERIC) and telecommunications companies VEON (VEON), which fell 1.3% and 0.9% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which soared 61.2%, followed by biotech firm Trinity Biotech (TRIB) and software firm Endava (DAVA), which increased 3.8% and 2.9% respectively, while medical device maker Smith & Nephew (SNN) was up 1.7%.

The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana (NCNA) and TC Biopharm (TCBP), which fell 5.3% and 0.8% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX), which was down 0.9%.